% | $
Quotes you view appear here for quick access.

AcelRx Pharmaceuticals, Inc. Message Board

  • tvmanjon tvmanjon Dec 21, 2012 12:50 PM Flag

    More down side sorry

    no immediate catalyst Down side $3.50

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I stubmbled onto this jewel last week after hours and hours of DD....MANY catalysts coming in 2013 ...Just look at the Seeking Alpha article by "Chemist Frog" as starters...

      "AcelRx investors should be anticipating an exciting 2013 ahead. Q1 will likely witness data release of its other two Phase III trials for ARX-01 with a subsequent new drug application (NDA) sometime in mid year. If all goes as planned, the company should receive a regulatory decision from the FDA in 2H, providing a full year of major catalysts for the company in 2013. Another catalyst that will likely be impactful first will be a regulatory decision by the European Medicines Agency (EMA) in 1H for ARX-01. An October 3rd, 2012 announcement by the company noted that the three Phase III trials' data would be sufficient to meet EMA requirements for regulatory approval if the data were positive. The trials would be helping AcelRx get the most "bang for its buck" as additional positive data from the remaining trials could mean not only an FDA approval in the U.S., but also a marketing approval for the 31 EU/EFTA (European Union/European Free Trade Association) countries representing a population of over 500 million people."

    • Perhaps---but the intermediate and longer term upside risk is much greater than the near term downside risk, at the present---imo.

      Sentiment: Buy

3.89+0.17(+4.57%)Sep 30 4:00 PMEDT